The Hepatitis B virus (HBV) belongs to the hepatotropic DNA virus family, the
Hepadnaviridae. It is a small, enveloped virus with a circular, partially double-stranded DNA genome of 3.2 kb, which replicates exclusively in the liver and causes hepatitis B (
1). In spite of available vaccines, worldwide 350 million people are chronically infected with HBV, of which 1 million die per year from liver cirrhosis and HCC (
2) underscoring the need for novel therapeutic approaches.
After infection of the cell, the viral genome is delivered into the nucleus. The partially double-stranded viral genome is converted by host enzymes to a covalently closed, circular, double-stranded DNA molecule (cccDNA). The minus strand of the cccDNA represents the template for all viral transcripts. Starting at four different promoters (A) the six different viral mRNAs are transcribed by cellular RNA polymerase II. All viral mRNAs are capped and share an identical 3′-end due to the utilization of the same polyadenylation site. The unspliced viral transcripts are exported into the cytoplasm, where translation of the viral polymerase, the core protein, the X protein and the three different surface proteins takes place. The pre-genomic RNA encodes the polymerase and the core protein, is reverse transcribed into genomic minus strand DNA and is also encapsidated (
1–3).
Although the viral RNA contains a variety of splice donor and splice acceptor sites the majority of the viral RNAs escape the splicing machinery and are exported in a splice-independent manner. The nuclear export of the unspliced RNAs encoding the surface proteins is facilitated by the
cis-active hepatitis B virus post-transcriptional regulatory element (HPRE) (
4,
5), whereas the export mechanism for the unspliced pregenomic RNA is still elusive (
6). The HPRE is contained in all viral transcripts at their 3′-end and partially overlaps with the ORFs encoding the protein X and the polymerase.
Splicing of viral RNAs (
7–14), the expression of the HBV splice-generated protein (HBSP) (
15,
16) and a polymerase and surface fusion protein (
17) are well documented. However, the function of splicing in the viral life cycle and/or during infection is still enigmatic. In addition to its export function, the HPRE contains a splicing enhancer element indicative for an additional splicing regulatory function (
6).
The HPRE is an ~500 nt long tripartite element consisting of the sub-elements α (nucleotides1151–1346), β1 (nucleotides 1347–1457) and β2 (nucleotides 1458–1582) (A) (
18). All three sub-elements alone can facilitate nuclear export albeit with very low efficiency indicating that all three elements are required for full HPRE activity (
18–20). Two stem-loops have been identified in the sub-elements, SLα (nucleotides 1292–1321) and SLβ1 (nucleotides 1410–1434). Disruption of the stem integrity results in a decrease of HPRE activity comparable to the loss of activity after deletion of the whole corresponding sub-element. Compensatory mutations that restore the stem integrity also restored export activity (
18). These experiments led to the prediction that both hairpins serve as protein-binding sites for nuclear export factors. Note, that the sequence of the SLα is highly conserved between HBV and the closely related woodchuck hepatitis virus (
18).
Secondary structure prediction based on the conserved sequences of SLα indicates that the stem is closed by a pentaloop and that the stem is interrupted by a bulged guanine (B). The HPRE facilitates the nuclear export of viral transcripts most likely by recruiting
trans-acting host proteins. So far, three proteins, including the poly-pyrimidine tract binding protein (PTB), have been described to bind to the HPRE (
21–23). Binding sites for the PTB were identified in the 3′-region of the HPRE and functional PTB-binding sites were shown to be important for HPRE-dependent reporter gene expression (
23,
24) even though its direct role in HBV mRNA export remains to be shown [(
25); see also (
26)]. As RNA export is mediated by specific protein factors (
26) and RNA–protein interactions frequently involve non-canonical RNA structures (
27,
28), it is conceivable that the non-canonical parts of the SLα, i.e. the pentaloop and the bulged guanine, might constitute protein recognition sites functionally important in HBV mRNA export. This idea is consistent with recent findings that RNA hairpins containing pentaloop sequences similar to but non-identical with the SLα pentaloop bind SAM domain containing proteins in the yeast
Saccharomyces cerevisiae (
29,
30). Nuclear export of unspliced HBV RNAs is a bottleneck in the viral life cycle and represents a potential target for therapeutic intervention. The documented contribution of the SLα domain to the function of the HPRE and its potential to be used as a drug target served as incentive to determine the structure of SLα.